Global Genome-Based Drug Sales Market Report 2023

Report ID: 889719 | Published Date: Jan 2025 | No. of Page: 145 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Genome-Based Drug Market Overview
    1.1 Genome-Based Drug Product Scope
    1.2 Genome-Based Drug Segment by Type
        1.2.1 Global Genome-Based Drug Sales by Type (2016 & 2021 & 2027)
        1.2.2 Insulin
        1.2.3 Growth Hormone
        1.2.4 Monoclonal Antibody
        1.2.5 Other
    1.3 Genome-Based Drug Segment by Application
        1.3.1 Global Genome-Based Drug Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 Hospital
        1.3.3 Pharmaceutical Factory
        1.3.4 Other
    1.4 Genome-Based Drug Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Genome-Based Drug Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Genome-Based Drug Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Genome-Based Drug Price Trends (2016-2027)

2 Genome-Based Drug Estimates and Forecasts by Region
    2.1 Global Genome-Based Drug Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Genome-Based Drug Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Genome-Based Drug Sales Market Share by Region (2016-2021)
        2.2.2 Global Genome-Based Drug Revenue Market Share by Region (2016-2021)
    2.3 Global Genome-Based Drug Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Genome-Based Drug Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Genome-Based Drug Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Genome-Based Drug Estimates and Projections (2016-2027)
        2.4.2 Europe Genome-Based Drug Estimates and Projections (2016-2027)
        2.4.3 China Genome-Based Drug Estimates and Projections (2016-2027)
        2.4.4 Japan Genome-Based Drug Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Genome-Based Drug Estimates and Projections (2016-2027)
        2.4.6 India Genome-Based Drug Estimates and Projections (2016-2027)
3 Global Genome-Based Drug Competition Landscape by Players
    3.1 Global Top Genome-Based Drug Players by Sales (2016-2021)
    3.2 Global Top Genome-Based Drug Players by Revenue (2016-2021)
    3.3 Global Genome-Based Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genome-Based Drug as of 2020)
    3.4 Global Genome-Based Drug Average Price by Company (2016-2021)
    3.5 Manufacturers Genome-Based Drug Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Genome-Based Drug Market Size by Type
    4.1 Global Genome-Based Drug Historic Market Review by Type (2016-2021)
        4.1.1 Global Genome-Based Drug Sales Market Share by Type (2016-2021)
        4.1.2 Global Genome-Based Drug Revenue Market Share by Type (2016-2021)
        4.1.3 Global Genome-Based Drug Price by Type (2016-2021)
    4.2 Global Genome-Based Drug Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Genome-Based Drug Sales Forecast by Type (2022-2027)
        4.2.2 Global Genome-Based Drug Revenue Forecast by Type (2022-2027)
        4.2.3 Global Genome-Based Drug Price Forecast by Type (2022-2027)
5 Global Genome-Based Drug Market Size by Application
    5.1 Global Genome-Based Drug Historic Market Review by Application (2016-2021)
        5.1.1 Global Genome-Based Drug Sales Market Share by Application (2016-2021)
        5.1.2 Global Genome-Based Drug Revenue Market Share by Application (2016-2021)
        5.1.3 Global Genome-Based Drug Price by Application (2016-2021)
    5.2 Global Genome-Based Drug Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Genome-Based Drug Sales Forecast by Application (2022-2027)
        5.2.2 Global Genome-Based Drug Revenue Forecast by Application (2022-2027)
        5.2.3 Global Genome-Based Drug Price Forecast by Application (2022-2027)

6 North America Genome-Based Drug Market Facts & Figures
    6.1 North America Genome-Based Drug Sales by Company
        6.1.1 North America Genome-Based Drug Sales by Company (2016-2021)
        6.1.2 North America Genome-Based Drug Revenue by Company (2016-2021)
    6.2 North America Genome-Based Drug Sales Breakdown by Type
        6.2.1 North America Genome-Based Drug Sales Breakdown by Type (2016-2021)
        6.2.2 North America Genome-Based Drug Sales Breakdown by Type (2022-2027)
    6.3 North America Genome-Based Drug Sales Breakdown by Application
        6.3.1 North America Genome-Based Drug Sales Breakdown by Application (2016-2021)
        6.3.2 North America Genome-Based Drug Sales Breakdown by Application (2022-2027)

7 Europe Genome-Based Drug Market Facts & Figures
    7.1 Europe Genome-Based Drug Sales by Company
        7.1.1 Europe Genome-Based Drug Sales by Company (2016-2021)
        7.1.2 Europe Genome-Based Drug Revenue by Company (2016-2021)
    7.2 Europe Genome-Based Drug Sales Breakdown by Type
        7.2.1 Europe Genome-Based Drug Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Genome-Based Drug Sales Breakdown by Type (2022-2027)
    7.3 Europe Genome-Based Drug Sales Breakdown by Application
        7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)

8 China Genome-Based Drug Market Facts & Figures
    8.1 China Genome-Based Drug Sales by Company
        8.1.1 China Genome-Based Drug Sales by Company (2016-2021)
        8.1.2 China Genome-Based Drug Revenue by Company (2016-2021)
    8.2 China Genome-Based Drug Sales Breakdown by Type
        8.2.1 China Genome-Based Drug Sales Breakdown by Type (2016-2021)
        8.2.2 China Genome-Based Drug Sales Breakdown by Type (2022-2027)
    8.3 China Genome-Based Drug Sales Breakdown by Application
        8.3.1 China 315 Sales Breakdown by Application (2016-2021)
        8.3.2 China 315 Sales Breakdown by Application (2022-2027)

9 Japan Genome-Based Drug Market Facts & Figures
    9.1 Japan Genome-Based Drug Sales by Company
        9.1.1 Japan Genome-Based Drug Sales by Company (2016-2021)
        9.1.2 Japan Genome-Based Drug Revenue by Company (2016-2021)
    9.2 Japan Genome-Based Drug Sales Breakdown by Type
        9.2.1 Japan Genome-Based Drug Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Genome-Based Drug Sales Breakdown by Type (2022-2027)
    9.3 Japan Genome-Based Drug Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Genome-Based Drug Market Facts & Figures
    10.1 Southeast Asia Genome-Based Drug Sales by Company
        10.1.1 Southeast Asia Genome-Based Drug Sales by Company (2016-2021)
        10.1.2 Southeast Asia Genome-Based Drug Revenue by Company (2016-2021)
    10.2 Southeast Asia Genome-Based Drug Sales Breakdown by Type
        10.2.1 Southeast Asia Genome-Based Drug Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Genome-Based Drug Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Genome-Based Drug Sales Breakdown by Application
        10.3.1 Southeast Asia Kiloton Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia Kiloton Sales Breakdown by Application (2022-2027)

11 India Genome-Based Drug Market Facts & Figures
    11.1 India Genome-Based Drug Sales by Company
        11.1.1 India Genome-Based Drug Sales by Company (2016-2021)
        11.1.2 India Genome-Based Drug Revenue by Company (2016-2021)
    11.2 India Genome-Based Drug Sales Breakdown by Type
        11.2.1 India Genome-Based Drug Sales Breakdown by Type (2016-2021)
        11.2.2 India Genome-Based Drug Sales Breakdown by Type (2022-2027)
    11.3 India Genome-Based Drug Sales Breakdown by Application
        11.3.1 India Genome-Based Drug Sales Breakdown by Application (2016-2021)
        11.3.2 India Genome-Based Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Genome-Based Drug Business
    12.1 Sandoz International
        12.1.1 Sandoz International Corporation Information
        12.1.2 Sandoz International Business Overview
        12.1.3 Sandoz International Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Sandoz International Genome-Based Drug Products Offered
        12.1.5 Sandoz International Recent Development
    12.2 Teva pharmaceutical industries
        12.2.1 Teva pharmaceutical industries Corporation Information
        12.2.2 Teva pharmaceutical industries Business Overview
        12.2.3 Teva pharmaceutical industries Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Teva pharmaceutical industries Genome-Based Drug Products Offered
        12.2.5 Teva pharmaceutical industries Recent Development
    12.3 Mylan
        12.3.1 Mylan Corporation Information
        12.3.2 Mylan Business Overview
        12.3.3 Mylan Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Mylan Genome-Based Drug Products Offered
        12.3.5 Mylan Recent Development
    12.4 3SBio
        12.4.1 3SBio Corporation Information
        12.4.2 3SBio Business Overview
        12.4.3 3SBio Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 3SBio Genome-Based Drug Products Offered
        12.4.5 3SBio Recent Development
    12.5 Shanghai Fosun Pharmaceutical
        12.5.1 Shanghai Fosun Pharmaceutical Corporation Information
        12.5.2 Shanghai Fosun Pharmaceutical Business Overview
        12.5.3 Shanghai Fosun Pharmaceutical Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Shanghai Fosun Pharmaceutical Genome-Based Drug Products Offered
        12.5.5 Shanghai Fosun Pharmaceutical Recent Development
    12.6 Tonghua Dongbao Pharmaceutical
        12.6.1 Tonghua Dongbao Pharmaceutical Corporation Information
        12.6.2 Tonghua Dongbao Pharmaceutical Business Overview
        12.6.3 Tonghua Dongbao Pharmaceutical Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Tonghua Dongbao Pharmaceutical Genome-Based Drug Products Offered
        12.6.5 Tonghua Dongbao Pharmaceutical Recent Development
    12.7 Biocon
        12.7.1 Biocon Corporation Information
        12.7.2 Biocon Business Overview
        12.7.3 Biocon Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Biocon Genome-Based Drug Products Offered
        12.7.5 Biocon Recent Development
    12.8 Reliance Life Sciences
        12.8.1 Reliance Life Sciences Corporation Information
        12.8.2 Reliance Life Sciences Business Overview
        12.8.3 Reliance Life Sciences Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Reliance Life Sciences Genome-Based Drug Products Offered
        12.8.5 Reliance Life Sciences Recent Development
    12.9 Probiomed
        12.9.1 Probiomed Corporation Information
        12.9.2 Probiomed Business Overview
        12.9.3 Probiomed Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Probiomed Genome-Based Drug Products Offered
        12.9.5 Probiomed Recent Development
    12.10 Biosidus
        12.10.1 Biosidus Corporation Information
        12.10.2 Biosidus Business Overview
        12.10.3 Biosidus Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Biosidus Genome-Based Drug Products Offered
        12.10.5 Biosidus Recent Development
    12.11 AMEGA Biotech
        12.11.1 AMEGA Biotech Corporation Information
        12.11.2 AMEGA Biotech Business Overview
        12.11.3 AMEGA Biotech Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 AMEGA Biotech Genome-Based Drug Products Offered
        12.11.5 AMEGA Biotech Recent Development
    12.12 Celltrion
        12.12.1 Celltrion Corporation Information
        12.12.2 Celltrion Business Overview
        12.12.3 Celltrion Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 Celltrion Genome-Based Drug Products Offered
        12.12.5 Celltrion Recent Development
    12.13 LG Life Science
        12.13.1 LG Life Science Corporation Information
        12.13.2 LG Life Science Business Overview
        12.13.3 LG Life Science Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021)
        12.13.4 LG Life Science Genome-Based Drug Products Offered
        12.13.5 LG Life Science Recent Development
    12.14 Dong-A Pharmaceutical
        12.14.1 Dong-A Pharmaceutical Corporation Information
        12.14.2 Dong-A Pharmaceutical Business Overview
        12.14.3 Dong-A Pharmaceutical Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021)
        12.14.4 Dong-A Pharmaceutical Genome-Based Drug Products Offered
        12.14.5 Dong-A Pharmaceutical Recent Development

13 Genome-Based Drug Manufacturing Cost Analysis
    13.1 Genome-Based Drug Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Genome-Based Drug
    13.4 Genome-Based Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Genome-Based Drug Distributors List
    14.3 Genome-Based Drug Customers

15 Market Dynamics
    15.1 Genome-Based Drug Market Trends
    15.2 Genome-Based Drug Drivers
    15.3 Genome-Based Drug Market Challenges
    15.4 Genome-Based Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer
List of Tables
    Table 1. Global Genome-Based Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Genome-Based Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Genome-Based Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Genome-Based Drug Sales (Kiloton) by Region (2016-2021)
    Table 5. Global Genome-Based Drug Sales Market Share by Region (2016-2021)
    Table 6. Global Genome-Based Drug Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Genome-Based Drug Revenue Share by Region (2016-2021)
    Table 8. Global Genome-Based Drug Sales (Kiloton) Forecast by Region (2022-2027)
    Table 9. Global Genome-Based Drug Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Genome-Based Drug Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Genome-Based Drug Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Genome-Based Drug Sales (Kiloton) of Key Companies (2016-2021)
    Table 13. Global Genome-Based Drug Sales Share by Company (2016-2021)
    Table 14. Global Genome-Based Drug Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Genome-Based Drug Revenue Share by Company (2016-2021)
    Table 16. Global Genome-Based Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genome-Based Drug as of 2020)
    Table 17. Global Genome-Based Drug Average Price (US$/Ton) of Key Company (2016-2021)
    Table 18. Manufacturers Genome-Based Drug Manufacturing Sites and Area Served
    Table 19. Manufacturers Genome-Based Drug Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Genome-Based Drug Sales (Kiloton) by Type (2016-2021)
    Table 22. Global Genome-Based Drug Sales Share by Type (2016-2021)
    Table 23. Global Genome-Based Drug Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Genome-Based Drug Price (US$/Ton) by Type (2016-2021)
    Table 25. Global Genome-Based Drug Sales Share by Type (2022-2027)
    Table 26. Global Genome-Based Drug Revenue (US$ Million) Market Share by Type (2022-2027) 
    Table 27. Global Genome-Based Drug Revenue Share by Type (2022-2027)
    Table 28. Global Genome-Based Drug Price (US$/Ton) by Type (2022-2027)
    Table 29. Global Genome-Based Drug Sales (Kiloton) by Application (2016-2021) 
    Table 30. Global Genome-Based Drug Sales Share by Application (2016-2021)
    Table 31. Global Genome-Based Drug Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Genome-Based Drug Price (US$/Ton) by Application (2016-2021)
    Table 33. Global Genome-Based Drug Sales (Kiloton) by Application (2022-2027)
    Table 34. Global Genome-Based Drug Sales Share by Application (2022-2027)
    Table 35. Global Genome-Based Drug Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Genome-Based Drug Revenue Share by Application (2022-2027)
    Table 37. Global Genome-Based Drug Price (US$/Ton) by Application (2022-2027)
    Table 38. North America Genome-Based Drug Sales (Kiloton) by Company (2016-2021)
    Table 39. North America Genome-Based Drug Sales Market Share by Company (2016-2021)
    Table 40. North America Genome-Based Drug Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Genome-Based Drug Revenue Market Share by Company (2016-2021)
    Table 42. North America Genome-Based Drug Sales by Type (2016-2021) & (Kiloton)
    Table 43. North America Genome-Based Drug Sales Market Share by Type (2016-2021)
    Table 44. North America Genome-Based Drug Sales by Type (2022-2027) & (Kiloton)
    Table 45. North America Genome-Based Drug Sales Market Share by Type (2022-2027)
    Table 46. North America Genome-Based Drug Sales by Application (2016-2021) & (Kiloton)
    Table 47. North America Genome-Based Drug Sales Market Share by Application (2016-2021)
    Table 48. North America Genome-Based Drug Sales by Application (2022-2027) & (Kiloton)
    Table 49. North America Genome-Based Drug Sales Market Share by Application (2022-2027)
    Table 50. Europe Genome-Based Drug Sales (Kiloton) by Company (2016-2021)
    Table 51. Europe Genome-Based Drug Sales Market Share by Company (2016-2021)
    Table 52. Europe Genome-Based Drug Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Genome-Based Drug Revenue Market Share by Company (2016-2021)
    Table 54. Europe Genome-Based Drug Sales by Type (2016-2021) & (Kiloton)
    Table 55. Europe Genome-Based Drug Sales Market Share by Type (2016-2021)
    Table 56. Europe Genome-Based Drug Sales by Type (2022-2027) & (Kiloton)
    Table 57. Europe Genome-Based Drug Sales Market Share by Type (2022-2027)
    Table 58. Europe Genome-Based Drug Sales by Application (2016-2021) & (Kiloton)
    Table 59. Europe Genome-Based Drug Sales Market Share by Application (2016-2021)
    Table 60. Europe Genome-Based Drug Sales by Application (2022-2027) & (Kiloton)
    Table 61. Europe Genome-Based Drug Sales Market Share by Application (2022-2027)
    Table 62. China Genome-Based Drug Sales (Kiloton) by Company (2016-2021)
    Table 63. China Genome-Based Drug Sales Market Share by Company (2016-2021)
    Table 64. China Genome-Based Drug Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Genome-Based Drug Revenue Market Share by Company (2016-2021)
    Table 66. China Genome-Based Drug Sales by Type (2016-2021) & (Kiloton)
    Table 67. China Genome-Based Drug Sales Market Share by Type (2016-2021)
    Table 68. China Genome-Based Drug Sales by Type (2022-2027) & (Kiloton)
    Table 69. China Genome-Based Drug Sales Market Share by Type (2022-2027)
    Table 70. China Genome-Based Drug Sales by Application (2016-2021) & (Kiloton)
    Table 71. China Genome-Based Drug Sales Market Share by Application (2016-2021)
    Table 72. China Genome-Based Drug Sales by Application (2022-2027) & (Kiloton)
    Table 73. China Genome-Based Drug Sales Market Share by Application (2022-2027)
    Table 74. Japan Genome-Based Drug Sales (Kiloton) by Company (2016-2021)
    Table 75. Japan Genome-Based Drug Sales Market Share by Company (2016-2021)
    Table 76. Japan Genome-Based Drug Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Genome-Based Drug Revenue Market Share by Company (2016-2021)
    Table 78. Japan Genome-Based Drug Sales by Type (2016-2021) & (Kiloton)
    Table 79. Japan Genome-Based Drug Sales Market Share by Type (2016-2021)
    Table 80. Japan Genome-Based Drug Sales by Type (2022-2027) & (Kiloton)
    Table 81. Japan Genome-Based Drug Sales Market Share by Type (2022-2027)
    Table 82. Japan Genome-Based Drug Sales by Application (2016-2021) & (Kiloton)
    Table 83. Japan Genome-Based Drug Sales Market Share by Application (2016-2021)
    Table 84. Japan Genome-Based Drug Sales by Application (2022-2027) & (Kiloton)
    Table 85. Japan Genome-Based Drug Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Genome-Based Drug Sales (Kiloton) by Company (2016-2021)
    Table 87. Southeast Asia Genome-Based Drug Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Genome-Based Drug Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Genome-Based Drug Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Genome-Based Drug Sales by Type (2016-2021) & (Kiloton)
    Table 91. Southeast Asia Genome-Based Drug Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Genome-Based Drug Sales by Type (2022-2027) & (Kiloton)
    Table 93. Southeast Asia Genome-Based Drug Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Genome-Based Drug Sales by Application (2016-2021) & (Kiloton)
    Table 95. Southeast Asia Genome-Based Drug Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Genome-Based Drug Sales by Application (2022-2027) & (Kiloton)
    Table 97. Southeast Asia Genome-Based Drug Sales Market Share by Application (2022-2027)
    Table 98. India Genome-Based Drug Sales (Kiloton) by Company (2016-2021)
    Table 99. India Genome-Based Drug Sales Market Share by Company (2016-2021)
    Table 100. India Genome-Based Drug Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Genome-Based Drug Revenue Market Share by Company (2016-2021)
    Table 102. India Genome-Based Drug Sales by Type (2016-2021) & (Kiloton)
    Table 103. India Genome-Based Drug Sales Market Share by Type (2016-2021)
    Table 104. India Genome-Based Drug Sales by Type (2022-2027) & (Kiloton)
    Table 105. India Genome-Based Drug Sales Market Share by Type (2022-2027)
    Table 106. India Genome-Based Drug Sales by Application (2016-2021) & (Kiloton)
    Table 107. India Genome-Based Drug Sales Market Share by Application (2016-2021)
    Table 108. India Genome-Based Drug Sales by Application (2022-2027) & (Kiloton)
    Table 109. India Genome-Based Drug Sales Market Share by Application (2022-2027)
    Table 110. Sandoz International Corporation Information
    Table 111. Sandoz International Description and Business Overview
    Table 112. Sandoz International Genome-Based Drug Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 113. Sandoz International Genome-Based Drug Product
    Table 114. Sandoz International Recent Development
    Table 115. Teva pharmaceutical industries Corporation Information
    Table 116. Teva pharmaceutical industries Description and Business Overview
    Table 117. Teva pharmaceutical industries Genome-Based Drug Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 118. Teva pharmaceutical industries Genome-Based Drug Product
    Table 119. Teva pharmaceutical industries Recent Development
    Table 120. Mylan Corporation Information
    Table 121. Mylan Description and Business Overview
    Table 122. Mylan Genome-Based Drug Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 123. Mylan Genome-Based Drug Product
    Table 124. Mylan Recent Development
    Table 125. 3SBio Corporation Information
    Table 126. 3SBio Description and Business Overview
    Table 127. 3SBio Genome-Based Drug Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 128. 3SBio Genome-Based Drug Product
    Table 129. 3SBio Recent Development
    Table 130. Shanghai Fosun Pharmaceutical Corporation Information
    Table 131. Shanghai Fosun Pharmaceutical Description and Business Overview
    Table 132. Shanghai Fosun Pharmaceutical Genome-Based Drug Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 133. Shanghai Fosun Pharmaceutical Genome-Based Drug Product
    Table 134. Shanghai Fosun Pharmaceutical Recent Development
    Table 135. Tonghua Dongbao Pharmaceutical Corporation Information
    Table 136. Tonghua Dongbao Pharmaceutical Description and Business Overview
    Table 137. Tonghua Dongbao Pharmaceutical Genome-Based Drug Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 138. Tonghua Dongbao Pharmaceutical Genome-Based Drug Product
    Table 139. Tonghua Dongbao Pharmaceutical Recent Development
    Table 140. Biocon Corporation Information
    Table 141. Biocon Description and Business Overview
    Table 142. Biocon Genome-Based Drug Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 143. Biocon Genome-Based Drug Product
    Table 144. Biocon Recent Development
    Table 145. Reliance Life Sciences Corporation Information
    Table 146. Reliance Life Sciences Genome-Based Drug Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 147. Reliance Life Sciences Description and Business Overview
    Table 148. Reliance Life Sciences Genome-Based Drug Product
    Table 149. Reliance Life Sciences Recent Development
    Table 150. Probiomed Corporation Information
    Table 151. Probiomed Genome-Based Drug Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 152. Probiomed Description and Business Overview
    Table 153. Probiomed Genome-Based Drug Product
    Table 154. Probiomed Recent Development
    Table 155. Biosidus Corporation Information
    Table 156. Biosidus Description and Business Overview
    Table 157. Biosidus Genome-Based Drug Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 158. Biosidus Genome-Based Drug Product
    Table 159. Biosidus Recent Development
    Table 160. AMEGA Biotech Corporation Information
    Table 161. AMEGA Biotech Description and Business Overview
    Table 162. AMEGA Biotech Genome-Based Drug Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 163. AMEGA Biotech Genome-Based Drug Product
    Table 164. AMEGA Biotech Recent Development
    Table 165. Celltrion Corporation Information
    Table 166. Celltrion Description and Business Overview
    Table 167. Celltrion Genome-Based Drug Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 168. Celltrion Genome-Based Drug Product
    Table 169. Celltrion Recent Development
    Table 170. LG Life Science Corporation Information
    Table 171. LG Life Science Description and Business Overview
    Table 172. LG Life Science Genome-Based Drug Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 173. LG Life Science Genome-Based Drug Product
    Table 174. LG Life Science Recent Development
    Table 175. Dong-A Pharmaceutical Corporation Information
    Table 176. Dong-A Pharmaceutical Description and Business Overview
    Table 177. Dong-A Pharmaceutical Genome-Based Drug Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 178. Dong-A Pharmaceutical Genome-Based Drug Product
    Table 179. Dong-A Pharmaceutical Recent Development
    Table 180. Production Base and Market Concentration Rate of Raw Material
    Table 181. Key Suppliers of Raw Materials
    Table 182. Genome-Based Drug Distributors List
    Table 183. Genome-Based Drug Customers List
    Table 184. Genome-Based Drug Market Trends
    Table 185. Genome-Based Drug Market Drivers
    Table 186. Genome-Based Drug Market Challenges
    Table 187. Genome-Based Drug Market Restraints
    Table 188. Research Programs/Design for This Report
    Table 189. Key Data Information from Secondary Sources
    Table 190. Key Data Information from Primary Sources
List of Figures
    Figure 1. Genome-Based Drug Product Picture
    Figure 2. Global Genome-Based Drug Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Genome-Based Drug Sales Market Share by Application in 2021 & 2027
    Figure 6. Hospital Examples
    Figure 7. Pharmaceutical Factory Examples
    Figure 8. Other Examples
    Figure 9. Global Genome-Based Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Genome-Based Drug Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 11. Global Genome-Based Drug Sales (Kiloton) Growth Rate (2016-2027)
    Figure 12. Global Genome-Based Drug Price Trends Growth Rate (2016-2027) (US$/Ton)
    Figure 13. Global Genome-Based Drug Revenue Market Share by Region: 2016 VS 2021
    Figure 14. Global Genome-Based Drug Revenue Market Share by Region: 2021 VS 2027
    Figure 15. North America Genome-Based Drug Revenue (Million USD) Growth Rate (2016-2027)
    Figure 16. North America Genome-Based Drug Sales (Kiloton) Growth Rate (2016-2027)
    Figure 17. Europe Genome-Based Drug Revenue (Million USD) Growth Rate (2016-2027)
    Figure 18. Europe Genome-Based Drug Sales (Million USD) Growth Rate (2016-2027)
    Figure 19. China Genome-Based Drug Revenue (Million USD) Growth Rate (2016-2027)
    Figure 20. China Genome-Based Drug Sales (Million USD) and Growth Rate (2016-2027)
    Figure 21. Japan Genome-Based Drug Revenue (Million USD) Growth Rate (2016-2027)
    Figure 22. Japan Genome-Based Drug Sales (Million USD) Growth Rate (2016-2027)
    Figure 23. Southeast Asia Genome-Based Drug Revenue (Million USD) Growth Rate (2016-2027)
    Figure 24. Southeast Asia Genome-Based Drug Sales (Million USD) Growth Rate (2016-2027)
    Figure 25. India Genome-Based Drug Revenue (Million USD) Growth Rate (2016-2027)
    Figure 26. India Genome-Based Drug Sales (Million USD) Growth Rate (2016-2027)
    Figure 27. Global 5 Largest Genome-Based Drug Players Market Share by Revenue in Genome-Based Drug: 2016 & 2020
    Figure 28. Genome-Based Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 29. Global Genome-Based Drug Revenue Share by Type (2016-2021)
    Figure 30. Global Genome-Based Drug Revenue Growth Rate by Type in 2016 & 2020
    Figure 31. Global Genome-Based Drug Revenue Share by Application (2016-2021)
    Figure 32. Global Genome-Based Drug Revenue Growth Rate by Application in 2016 & 2020
    Figure 33. North America Genome-Based Drug Sales Market Share by Type in 2020
    Figure 34. North America Genome-Based Drug Sales Market Share by Application in 2020
    Figure 35. Europe Genome-Based Drug Sales Market Share by Type in 2020
    Figure 36. Europe Genome-Based Drug Sales Market Share by Application in 2020
    Figure 37. China Genome-Based Drug Sales Market Share by Type in 2020
    Figure 38. China Genome-Based Drug Sales Market Share by Application in 2020
    Figure 39. Japan Genome-Based Drug Sales Market Share by Type in 2020
    Figure 40. Japan Genome-Based Drug Sales Market Share by Application in 2020
    Figure 41. Southeast Asia Genome-Based Drug Sales Market Share by Type in 2020
    Figure 42. Southeast Asia Genome-Based Drug Sales Market Share by Application in 2020
    Figure 43. India Genome-Based Drug Sales Market Share by Type in 2020
    Figure 44. India Genome-Based Drug Sales Market Share by Application in 2020
    Figure 45. Key Raw Materials Price Trend
    Figure 46. Manufacturing Cost Structure of Genome-Based Drug 
    Figure 47. Manufacturing Process Analysis of Genome-Based Drug
    Figure 48. Genome-Based Drug Industrial Chain Analysis
    Figure 49. Channels of Distribution
    Figure 50. Distributors Profiles
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation 
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sandoz International
Teva pharmaceutical industries
Mylan
3SBio
Shanghai Fosun Pharmaceutical
Tonghua Dongbao Pharmaceutical
Biocon
Reliance Life Sciences
Probiomed
Biosidus
AMEGA Biotech
Celltrion
LG Life Science
Dong-A Pharmaceutical
Frequently Asked Questions
Genome-Based Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Genome-Based Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Genome-Based Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports